Biotech Azitra, Inc. Announces Q3 2024 Financial Results and Provides Business Updates November 13, 2024
Biotech Nordic Bioscience receives Letter of Support from the FDA for the CPa9-HNE biomarker in inflammatory bowel diseases November 11, 2024
Biotech ARTHEx Biotech Announces Oral Presentation on ATX-01 at TIDES Europe Annual Meeting 2024 November 11, 2024
Biotech STORM Therapeutics Presents New Clinical Data on its First-in-Class METTL3 Inhibitor STC-15 at SITC 2024 November 11, 2024
Biotech Marengo Presents Promising First-in-Human Safety, Tolerability and Clinical Activity Data for its Lead Program, Invikafusp Alfa (STAR0602), at the 2024 SITC Annual Meeting November 10, 2024